C Technologies, Inc. is excited to announce its acquisition by Repligen Corporation. As a life science company, Repligen Corporation focuses on leading bioprocessing technologies.
"We are very proud of the progress and impact we have made in biopharma over the past decade. Our culture of technology innovation and customer centricity is what differentiates us and where we feel a real affinity with Repligen. We look forward to driving expanded, global adoption of our products and continuing to advance SoloVPE and FlowVPE as standard in the industry for off-line, at-line, and in-line protein concentration measurements". Craig Harrison, President and CEO of C Technologies, Inc.